ARE BISPHOSPHONATES SOLELY RESPONSIBLE FOR ATYPICAL FEMORAL FRACTURES? A CASE SERIES

被引：0
作者：
Jamal, M. S. [1 ]
Cockill, C. [1 ]
Knights, S. [1 ]
机构：
[1] YDH, Rheumatol, Yeovil, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.7058
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0493
引用
收藏
页码：453 / 454
页数：2
相关论文
共 2 条
  • [1] Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy
    Franceschetti, Paola
    Bondanelli, Marta
    Caruso, Gaetano
    Ambrosio, Maria Rosaria
    Lorusso, Vincenzo
    Zatelli, Maria Chiara
    Massari, Leo
    degli Uberti, Ettore C.
    [J]. BONE, 2013, 56 (02) : 426 - 431
  • [2] The incidence of and risk factors for developing atypical femoral fractures in Japan
    Saita, Yoshitomo
    Ishijima, Muneaki
    Mogami, Atsuhiko
    Kubota, Mitsuaki
    Baba, Tomonori
    Kaketa, Takefumi
    Nagao, Masashi
    Sakamoto, Yuko
    Sakai, Kensuke
    Homma, Yasuhiro
    Kato, Rui
    Nagura, Nana
    Miyagawa, Kei
    Wada, Tomoki
    Liu, Lizu
    Matsuoka, Joe
    Obayashi, Osamu
    Shitoto, Katsuo
    Nozawa, Masahiko
    Kajihara, Hajime
    Gen, Hogaku
    Kaneko, Kazuo
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2015, 33 (03) : 311 - 318
1